Evidence supporting the use of: Beta-sitosterol
For the health condition: Benign Prostate Hyperplasia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Beta-sitosterol is a plant-derived sterol that has been studied for its potential benefits in managing symptoms of Benign Prostatic Hyperplasia (BPH). Scientific interest in beta-sitosterol for BPH originates from its structural similarity to cholesterol and its potential to influence mechanisms involved in prostate growth and urinary symptoms. Several randomized, placebo-controlled clinical trials and meta-analyses, notably a 1999 meta-analysis published in the journal The Lancet, have found that beta-sitosterol can modestly improve urinary symptoms and flow measures in men with BPH compared to placebo. These improvements include increased peak urinary flow and reduced residual urine volume, which are clinically relevant for men experiencing lower urinary tract symptoms due to BPH.

However, beta-sitosterol does not appear to reduce prostate size or halt disease progression. The exact mechanism of action is not fully understood, but it may involve inhibition of 5-alpha-reductase (an enzyme targeted by some prescription BPH medications), anti-inflammatory effects, or interference with the absorption of cholesterol in the intestines. The evidence base is limited by the relatively small number of high-quality long-term studies and a lack of direct comparison with standard medications. Side effects are generally mild and similar to placebo. Overall, while beta-sitosterol has more scientific support than many herbal therapies for BPH, it should not be considered a replacement for conventional treatment, especially in moderate to severe cases.

More about beta-sitosterol
More about Benign Prostate Hyperplasia